Search
Total Count 69

SPIMACO - Disclosures

SPIMACO board proposes to withhold 2023 dividends

Argaam 31/03/2024

SPIMACO signs term sheet to supply HPV vaccines

Argaam 23/01/2024

SPIMACO completes full acquisition of Dammam Pharma

Argaam 17/12/2023

SPIMACO’s subsidiary seals deal with Merck to manufacture type 2 diabetes meds in KSA

Argaam 19/11/2023

SPIMACO to transfer SAR 184.7 mln from reserves to offset accumulated losses

Argaam 15/11/2023

SPIMACO inks SPAs to acquire 68% of Osmopharm, divests 76.4% of SPIMACO Misr

Argaam 14/11/2023

SPIMACO secures SAR 300 mln credit facility from BSF

Argaam 14/06/2023

SPIMACO board proposes 815,000 share buyback for LTIP

Argaam 11/06/2023

SPIMACO board recommends no dividend for 2022

Argaam 29/03/2023

SPIMACO to hold virtual capital markets day to outline revamped 5-year plan today

Argaam 07/02/2023

SPIMACO signs SAR 900 mln credit facilities with SABB, Al Rajhi Bank

Argaam 29/12/2022

SPIMACO finalizes permits to occupy Riyadh administrative tower

Argaam 25/12/2022

SPIMACO set to launch revamped 5-year plan

Argaam 19/12/2022

SPIMACO signs credit facilities with 3 banks for SAR 1.26 bln

Argaam 29/08/2022

SPIMACO board plans 6% cash dividend for 2021

Argaam 24/03/2022

SPIMACO signs SAR 240 mln deal with Swiss firm to localize injection manufacturing

Argaam 17/01/2022

SPIMACO says ANORA shareholders approve voluntary liquidation, appoint liquidator

Argaam 18/11/2021

SPIMACO signs SAR 150 mln Murabaha agreement with Saudi EXIM Bank

Argaam 04/11/2021

SPIMACO signs SAR 160.3 mln contract with Ibrahim Alhodaithy International

Argaam 05/10/2021

SPIMACO announces legal measures for violations in subsidiary outside Saudi Arabia

Argaam 29/06/2021

SPIMACO shareholders approve 10% cash dividend for 2020

Argaam 31/05/2021

SPIMACO inks final agreement with Swiss pharma firm to locally manufacture immunosuppressive drug

Argaam 28/04/2021

SPIMACO plans 10% cash dividend for 2020

Argaam 23/03/2021

SPIMACO says fire erupted at warehouse of 51%-owned subsidiary

Argaam 24/01/2021

SPIMACO signs MoU with German firm to provide COVID-19 vaccine in Saudi Arabia

Argaam 29/11/2020

SPIMACO’s Morocco plant approves capital hike to continue project finance

Argaam 10/11/2020

SPIMACO signs MoU with Johnson & Johnson subsidiary to transfer, nationalize pharma technology

Argaam 20/09/2020

SPIMACO to voluntary liquidate a subsidiary

Argaam 17/09/2020

SPIMACO sells part of equity investment portfolio for SAR 482 mln

Argaam 16/09/2020

SPIMACO says accumulated losses down to 19.13% of capital as of June 30

Argaam 18/08/2020

SPIMACO approves 5% cash dividend for FY2019

Argaam 17/05/2020

SPIMACO signs deal with Amgen to market a biotech medicine

Argaam 29/04/2020

SPIMACO says difficult to determine financial impact of COVID-19 measures

Argaam 19/04/2020

SPIMACO board recommends 5% dividend for FY 2019

Argaam 31/03/2020

SPIMACO receives initial findings of its associate company’s fraud case

Argaam 08/12/2019

SPIMACO gets SAR 150 mln loan from SIDF to boost exports

Argaam 27/08/2019

SPIMACO appoints new chairman

Argaam 03/04/2019

SPIMACO approves 10% dividend for H2 2018

Argaam 03/04/2019

SPIMACO Egypt approves amending capital hike

Argaam 05/03/2019

SPIMACO recommends 10% dividend for H2 2018

Argaam 05/03/2019

SPIMACO refuses shareholder request to sack board of directors

Argaam 13/01/2019

SPIMACO approves Dammam Pharma's 50% capital hike

Argaam 27/12/2018

SPIMACO to discuss board dismissal, new audit committee in January

Argaam 27/11/2018

SPIMACO to move ops to Riyadh administrative tower by Q1 2019

Argaam 01/11/2018

SPIMACO signs SAR 189 mln contracts with health ministry

Argaam 03/09/2018

SPIMACO plans 5% dividend for H1 2018

Argaam 31/07/2018

SPIMACO to pump SAR 14.6 mln for SPIMACO Egypt’s capital hike

Argaam 03/05/2018

SPIMACO approves 10% dividend for FY17

Argaam 22/04/2018

SPIMACO shareholders to vote on 10% dividend Apr. 19

Argaam 03/04/2018

SPIMACO recommends 10% dividend for FY17

Argaam 22/03/2018

SPIMACO’s shareholders approve board rules, policies

Argaam 25/12/2017

SPIMACO’s Arac Healthcare to set up new SAR 5 mln subsidiary

Argaam 04/06/2015

SPIMACO greenlights $53.33 mln cancer treatment project

Argaam 04/06/2015

SPIMACO sells stake in EirGen Pharma for SAR 152.4 mln profit

Argaam 06/05/2015

SPIMACO to sell stake in foreign investment for SAR 150 mln profit

Argaam 04/05/2015

SPIMACO set to acquire 51% stake in Egypt’s Meivo ​

Argaam 04/05/2015

SPIMACO to issue 15% dividend for 2014

ِArgaam 26/04/2015

SPIMACO to up its stake in E-Pharma Morocco through capital raise

Argaam 26/04/2015

SPIMACO recommends 15% cash dividend for 2014

Argaam 17/02/2015

SPIMACO signs 5-year contract with F. Hoffman to distribute tumor medications

Argaam 13/01/2015

SPIMACO liquidates Dawa'akoum and removes it from the commercial register

Argaam 08/12/2014

SPIMACO signs SAR 134m contract for the execution of its Dammam project

Argaam 29/09/2014

SPIMACO’s board approves 50% capital raise of its affiliate

Argaam 15/06/2014

Saudi Spimaco to increase capital of Arak Healthcare by 500 percent

Argaam 20/04/2014

SPIMACOADDWAEIH 's GA approves 52.98 % capital raise and 10% cash dividends

Argaam 17/04/2014

SPIMACOADDWAEIH board recommends 52.98 % capital raise

Tadawul 23/02/2014

Saudi SPIMACO to build SAR 100 million office tower in Riyadh

Argaam 23/02/2014

SPIMACO restructures Dammam Pharma’s Capital:

Argaam 24/09/2013

SPIMACO establishes Dammam Pharma Company for SAR 120m:

Argaam 11/09/2012